Rezolute, Inc. (RZLT)

NASDAQ

$3.60

$-0.28

(-7.31%)

Regular Market

Rezolute, Inc. (RZLT) Live Price Chart

Last updated: ⁦2026-10-16 18:05:00⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

Rezolute, Inc. (RZLT) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $3.60, with a market capitalisation of $409.14M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.07 to $11.46. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$409.14M
Open	$3.90
Day's High	$21.11
Day's Low	$0.72
Previous Close	$3.90
Volume	925.53K
Average Volume	1.50M
P/E Ratio	--
52-Week High	$11.46
52-Week Low	$1.07
Dividend Yield	--
Earnings Date	--

Rezolute, Inc. (RZLT) Stock Price Today

Rezolute, Inc. (RZLT) is currently trading at $3.60 as of 2026-10-16 17:48:12, down 7.82% ($0.30) from the previous close of $3.90

During today's regular trading session, RZLT has traded between $0.72 and $21.11, with a trading volume of 925.53K shares. The current price is near the lower end of today's range.

Rezolute, Inc. (RZLT) 7-Day Stock Price Change

Over the past seven days, Rezolute, Inc. (RZLT) moved from $4.38 to $3.60, representing a decline of 17.92% ($0.78).

The stock traded between $3.60 and $4.91 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 1.73 million shares, down versus the previous seven-day period, indicating lower trading activity.

RZLT 52-Week Price Position

Position in Range: 24.3%

52W Low$1.07

52W High$11.46

RZLT is currently trading at $3.60, placing it 24.3% of the way from its 52-week low of $1.07 to its 52-week high of $11.46. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Rezolute, Inc. (RZLT)?

Rezolute Inc is a late-stage rare disease company focused on developing therapies that treat refractory and debilitating hypoglycemia associated with various forms of hyperinsulinism. Its main clinical asset, Ersodetug, is a potential treatment for refractory hypoglycemia caused by multiple forms of hyperinsulinism. The company has a single reportable segment, which includes all of its activities as a clinical-stage biopharmaceutical company.

Rezolute, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	58
Exchange	NASDAQ
Company Website	https://www.rezolutebio.com

How to Buy Rezolute, Inc. (RZLT) Stock on MEXC

Eligible investors can buy real shares of Rezolute, Inc. (RZLT) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for RZLT and Place Your Order

Open the RealStocks trading page and search for RZLT. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Rezolute, Inc. (RZLT) share price today?

Rezolute, Inc. (RZLT) is currently trading at $ 3.60, down 7.82% ($0.30) from the previous close of $ 3.90. Intraday prices update in real time during regular trading hours.

2.Is RZLT stock going up or down today?

As of 2026-10-16 17:48:12, RZLT is trading at $ 3.60, down 7.82% ($0.30) from its previous close of $ 3.90. The stock has traded between $ 0.72 and $ 21.11 during today’s regular session. Past price movements do not guarantee future results.

3.What is RZLT pre-market price?

As of 2026-10-16 17:48:12, RZLT is trading at $ 3.95 in pre-market trading, up 1.18% ($0.05) from the previous close of $ 3.90. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is RZLT after-hours price?

As of 2026-10-16 17:48:12, RZLT is trading at $ 3.93 in after-hours trading, up 0.77% ($0.03) from the regular-session close of $ 3.90. After-hours prices may differ from the regular session's opening price due to lower liquidity and wider bid-ask spreads.

5.Is RZLT stock trading now?

RZLT trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does RZLT sit relative to its 52-week high and low?

Over the past 52 weeks, RZLT has traded between a low of $ 1.07 and a high of $ 11.46. At $ 3.60, the stock is positioned 24.3% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Rezolute, Inc. in?

Rezolute, Inc. (RZLT) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Rezolute, Inc.'s market capitalisation and where is it listed?

Rezolute, Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 409.14M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is RZLT valued in terms of P/E ratio and EPS?

RZLT trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -0.80. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Rezolute, Inc. pay a dividend?

Rezolute, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.